RACGP is an influential group and this response likely to have some weight.
HomeAdvocacyReports andsubmissionsView allreports and submissions2023 reports andsubmissionsRACGPresponse to ACCC review of the merger between Australian Clinical Labs Limitedand Healius Lim
Date: 29 May2023
The RACGP hasresponded to the Australian Competition and Consumer Commission (ACCC) reviewof the merger between Australian Clinical Labs Limited (ACL) and HealiusLimited (Healius). The RACGP letter highlights the potential impacts of thismerger on access to healthcare for patients across Australia.
Readthe submission.Letter to ACCC re Pathology Merger- 29 May 2023 (PDF)
- Forums
- ASX - By Stock
- HLS
- RACGP response to ACCC review of the merger between Australian Clinical Labs Limited and Healius Limited
HLS
healius limited
Add to My Watchlist
0.60%
!
84.5¢

RACGP response to ACCC review of the merger between Australian Clinical Labs Limited and Healius Limited
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
84.5¢ |
Change
0.005(0.60%) |
Mkt cap ! $613.5M |
Open | High | Low | Value | Volume |
83.5¢ | 86.5¢ | 81.5¢ | $3.101M | 3.675M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 9 | 84.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
85.0¢ | 49196 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 760 | 0.840 |
2 | 11197 | 0.835 |
3 | 29229 | 0.830 |
2 | 1430 | 0.820 |
2 | 6190 | 0.815 |
Price($) | Vol. | No. |
---|---|---|
0.850 | 48111 | 4 |
0.860 | 9000 | 1 |
0.865 | 42445 | 2 |
0.870 | 48570 | 4 |
0.875 | 9398 | 1 |
Last trade - 16.10pm 08/08/2025 (20 minute delay) ? |
HLS (ASX) Chart |